|
Page: 20240510
|
David Cumming |
May 10, 2024
|
|
Page: Appendix A; Advisory Group
|
David Cumming |
May 10, 2024
|
|
Page: Appendix E,
|
David Cumming |
May 10, 2024
|
|
Page: Appendix F: Hydration and Solvation
|
David Cumming |
May 10, 2024
|
|
Page: April tbd
|
David Cumming |
May 10, 2024
|
|
Page: Canadian Clinical Drug Data Set
|
David Cumming |
May 10, 2024
|
|
Page: Canadian Clinical Drug Data Set Model
|
David Cumming |
May 10, 2024
|
|
Page: CCDD Release Notes
|
David Cumming |
May 10, 2024
|
|
Page: Combination Products
|
David Cumming |
May 10, 2024
|
|
Page: Dose Form for the NTP
|
David Cumming |
May 10, 2024
|
|
Page: Editorial Guidelines
|
David Cumming |
May 10, 2024
|
|
Home page: Home Page
|
David Cumming |
May 10, 2024
|
|
Page: Intended Use of the CCDD
|
David Cumming |
May 10, 2024
|
|
Page: Introduction
|
David Cumming |
May 10, 2024
|
|
Page: MP Formal Name Pattern
|
David Cumming |
May 10, 2024
|
|
Page: NTP Formal Name Patter
|
David Cumming |
May 10, 2024
|
|
Page: NTP Formal Name Pattern
|
David Cumming |
May 10, 2024
|
|
Page: Release notes
|
David Cumming |
May 10, 2024
|
|
Page: Release notes version 20191211
|
David Cumming |
May 10, 2024
|
|
Page: Release Schedules and Governance
|
David Cumming |
May 10, 2024
|
|
Page: Scope
|
David Cumming |
May 10, 2024
|
|
Page: Special Groupings
|
David Cumming |
May 10, 2024
|
|
Page: Status
|
David Cumming |
May 10, 2024
|
|
Page: Substance Strength Set
|
David Cumming |
May 10, 2024
|
|
Page: Technical Specification
|
David Cumming |
May 10, 2024
|
|
Page: Therapeutic Moiety
|
David Cumming |
May 10, 2024
|
|
Page: Unit of Presentation
|
David Cumming |
May 10, 2024
|